There has been a significant increase in the use of short-term percutaneous ventricular assist devices (pVADs) as acute circulatory support in cardiogenic shock and to provide haemodynamic support during interventional procedures, including high-risk percutaneous coronary interventions. Although frequently considered together, pVADs differ in their haemodynamic effects, management, indications, insertion techniques, and monitoring requirements. This consensus document summarizes the views of an expert panel by the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and the Association for Acute Cardiovascular Care (ACVC) and appraises the value of short-term pVAD. It reviews the pathophysiological context and possible indications for pVAD in different clinical settings and provides guidance regarding the management of pVAD based on existing evidence and best current practice.

3rd Department of Medicine Cardiology and Intensive Care Medicine Wilhelminenhospital Montleartstrasse 37 A 1160 Vienna and Sigmund Freud University Medical School Freudplatz 3 A 1020 Vienna Austria

Cardiac Center IKEM Prague Videnska 1958 9 14021 Prague 4 Czech Republic

Cardiac Intensive Care Unit IRCCS San Raffaele Scientific Institute Via Olgettina 60 20132 Milan Italy

Department of Adult Intensive Care Unit Royal Brompton and Harefield NHS Foundation Trust Royal Brompton Hospital Sydney Street SW3 6NP London UK

Department of Anesthesia and Intensive Care IRCCS ISMETT UPMC Italy Via Ernesto Triconi 5 94100 Palermo Italy

Department of Cardiology and Critical Care Medicine Jessa Ziekenhuis Stadsomvaart 11 3500 Hasselt Belgium and Faculty of Medicine and Life Sciences University of Hasselt Martelarenplein 42 3500 Hasselt Belgium

Department of Cardiology Copenhagen University Hospital Blegdamsvej 9 2100 Copenhagen Denmark

Department of Cardiology Copenhagen University Hospital Rigshospitalet Blegdamsvej 9 2100 Copenhagen Denmark

Department of Cardiology Oslo University Hospital Ullevål and University of Oslo Kirkeveien 166 0450 Oslo Norway

Department of Cardiovascular Diseases University Hospitals Leuven Herestraat 49 3000 Leuven Belgium

Department of Clinical Surgical Diagnostic and Pediatric Sciences University of Pavia Unit of Anaesthesia and Intensive Care Fondazione Policlinico San Matteo Hospital IRCCS Piazzale Golgi 19 27100 Pavia Italy

Department of Internal Medicine Cardiology Heart Center Leipzig at University of Leipzig and Leipzig Heart Institute Struempellstr 30 04289 Leipzig Germany

Department of Interventional Cardiology Erasmus University Medical Centre Dr Molewaterplein 40 3015 GD Rotterdam the Netherlands

Heart Center Trier Department of Internal Medicine 3 Krankenhaus der Barmherzigen Brüder Nordallee 1 54292 Trier Germany

Institute of Cardiology Jagiellonian University Medical College Krakow Poland and Maria Cecilia Hospital GVM Cotignola Ravenna Italy

Interventional Cardiology Unit Department of Cardiac Thoracic Vascular Sciences and Public Health University of Padova Via Giustiniani 2 35128 Padua Italy

Interventional Cardiology Unit IRCCS San Raffaele Scientific Institute Via Olgettina 60 20132 Milan Italy

Sorbonne Université INSERM UMRS_1166 ICAN Institute of Cardiometabolism and Nutrition and Department of Medical Intensive Care Unit Cardiology Institute Pitieé Salpeêtrieère Hospital Assistance Publique Hôpitaux de Paris Sorbonne University Medical School F 75013 Paris France

Translational and Clinical Research Institute Faculty of Medical Sciences Newcastle University and Cardiothoracic Centre Freeman Hospital Newcastle upon Tyne NHS Foundation Trust Newcastle upon Tyne NE2 4HH United Kingdom

See more in PubMed

Rihal CS, Naidu SS, Givertz MM, Szeto WY, Burke JA, Kapur NK, Kern M, Garratt KN, Goldstein JA, Dimas V, Tu T; American Heart Association (AHA), and American College of Cardiology (ACC). 2015 SCAI/ACC/HFSA/STS clinical expert consensus statement on the use of percutaneous mechanical circulatory support devices in cardiovascular care: endorsed by the American Heart Assocation, the Cardiological Society of India, and Sociedad Latino Americana de Cardiologia Intervencion; Affirmation of Value by the Canadian Association of Interventional Cardiology-Association Canadienne de Cardiologie d'intervention. J Am Coll Cardiol 2015;65:e7–e26. PubMed

Chieffo A, Burzotta F, Pappalardo F, Briguori C, Garbo R, Masiero G, Nicolini E, Ribichini F, Trani C, Álvarez BC, Leor OR, Moreno R, Santos R, Fiarresga A, Silveira JB, de Prado AP, Musumeci G, Esposito G, Tarantini G.. Clinical expert consensus document on the use of percutaneous left ventricular assist support devices during complex high-risk indicated PCI: Italian Society of Interventional Cardiology Working Group Endorsed by Spanish and Portuguese Interventional Cardiology Societies. Int J Cardiol 2019;293:84–90. PubMed

Henriques JPS, Ouweneel DM, Naidu SS, Palacios IF, Popma J, Ohman EM, O'Neill WW.. Evaluating the learning curve in the prospective Randomized Clinical Trial of hemodynamic support with Impella 2.5 versus Intra-Aortic Balloon Pump in patients undergoing high-risk percutaneous coronary intervention: a prespecified subanalysis of the PROTECT II study. Am Heart J 2014;167:472–479.e5. PubMed

Thiele H, Jobs A, Ouweneel DM, Henriques JPS, Seyfarth M, Desch S, Eitel I, Pöss J, Fuernau G, de Waha S.. Percutaneous short-term active mechanical support devices in cardiogenic shock: a systematic review and collaborative meta-analysis of randomized trials. Eur Heart J 2017;38:3523–3531. PubMed

Burkhoff D, Sayer G, Doshi D, Uriel N.. Hemodynamics of mechanical circulatory support. J Am Coll Card 2015;66:2663–2674. PubMed

Burkhoff D, Mirsky I, Suga H.. Assessment of systolic and diastolic ventricular properties via pressure-volume analysis: a guide for clinical, translational, and basic researchers. Am J Physiol Heart Circ Physiol 2005;289:H501–H512. PubMed

Korabathina R, Heffernan KS, Paruchuri V, Patel AR, Mudd JO, Prutkin JM, Orr NM, Weintraub A, Kimmelstiel CD, Kapur NK.. The pulmonary artery pulsatility index identifies severe right ventricular dysfunction in acute inferior myocardial infarction. Catheter Cardiovasc Interv 2012;80:593–600. PubMed

Kapur NK, Thayer KL, Zweck E.. Cardiogenic shock in the setting of acute myocardial infarction. Methodist Debakey Cardiovasc J 2020;16:16–21. PubMed PMC

Van Mieghem NM, Daemen J, den Uil C, Dur O, Joziasse L, Maugenest A-M, Fitzgerald K, Parker C, Muller P, van Geuns R-J.. Design and principle of operation of the HeartMate PHP (percutaneous heart pump). EuroIntervention 2018;13:1662–1666. PubMed

Perera D, Stables R, Clayton T, De Silva K, Lumley M, Clack L, Thomas M, Redwood S.. Long-term mortality data from the balloon pump-assisted coronary intervention study (BCIS-1): a randomized, controlled trial of elective balloon counterpulsation during high-risk percutaneous coronary intervention. Circulation 2013;127:207–212. PubMed

O'Neill WW, Kleiman NS, Moses J, Henriques JPS, Dixon S, Massaro J, Palacios I, Maini B, Mulukutla S, Dzavík V, Popma J, Douglas PS, Ohman M.. A prospective randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II Study. Circulation 2012;126:1717–1727. PubMed

Sjauw KD, Konorza T, Erbel R, Danna PL, Viecca M, Minden H-H, Butter C, Engstrøm T, Hassager C, Machado FP, Pedrazzini G, Wagner DR, Schamberger R, Kerber S, Mathey DG, Schofer J, Engström AE, Henriques JPS.. Supported high-risk percutaneous coronary intervention with the Impella 2.5 device the Europella registry. J Am Coll Cardiol 2009;54:2430–2434. PubMed

Maini B, Naidu SS, Mulukutla S, Kleiman N, Schreiber T, Wohns D, Dixon S, Rihal C, Dave R, O'Neill W.. Real-world use of the Impella 2.5 circulatory support system in complex high-risk percutaneous coronary intervention: the USpella Registry. Catheter Cardiovasc Interv 2012;80:717–725. PubMed

Baumann S, Werner N, Ibrahim K, Westenfeld R, Al-Rashid F, Sinning J-M, Westermann D, Schäfer A, Karatolios K, Bauer T, Becher T, Akin I.. Indication and short-term clinical outcomes of high-risk percutaneous coronary intervention with microaxial Impella® pump: results from the German Impella(R) registry. Clin Res Cardiol 2018;107:653–657. PubMed

Chieffo A, Ancona MB, Burzotta F, Pazzanese V, Briguori C, Trani C, Piva T, De Marco F, Di Biasi M, Pagnotta P, Casu G, Giustino G, Montorfano M, Pappalardo F, Tarantini G; Collaborators. Observational Multicenter Registry of Patients Treated with IMPella Mechanical Circulatory Support Device in ITaly: the IMP-IT Registry. EuroIntervention 2020;15:e1343–e1350. PubMed

Myat A, Patel N, Tehrani S, Banning AP, Redwood SR, Bhatt DL.. Percutaneous circulatory assist devices for high-risk coronary intervention. JACC Cardiovasc Interv 2015;8:229–244. PubMed

Patel MR, Smalling RW, Thiele H, Barnhart HX, Zhou Y, Chandra P, Chew D, Cohen M, French J, Perera D, Ohman EM.. Intra-aortic balloon counterpulsation and infarct size in patients with acute anterior myocardial infarction without shock: The CRISP AMI Randomized Trial. JAMA 2011;306:1329–1337. PubMed

Stone GW, Marsalese D, Brodie BR, Griffin JJ, Donohue B, Costantini C, Balestrini C, Wharton T, Esente P, Spain M, Moses J, Nobuyoshi M, Ayres M, Jones D, Mason D, Grines L, O'Neill WW, Grines CL.. A prospective, randomized evaluation of prophylactic intraaortic balloon counterpulsation in high risk patients with acute myocardial infarction treated with primary angioplasty. Second Primary Angioplasty in Myocardial Infarction (PAMI-II) Trial Investigators. J Am Coll Cardiol 1997;29:1459–1467. PubMed

Kapur NK, Paruchuri V, Urbano-Morales JA, Mackey EE, Daly GH, Qiao X, Pandian N, Perides G, Karas RH.. Mechanically unloading the left ventricle before coronary reperfusion reduces left ventricular wall stress and myocardial infarct size. Circulation 2013;128:328–336. PubMed

Esposito ML, Zhang Y, Qiao X, Reyelt L, Paruchuri V, Schnitzler GR, Morine KJ, Annamalai SK, Bogins C, Natov PS, Pedicini R, Breton C, Mullin A, Mackey EE, Patel A, Rowin E, Jaffe IZ, Karas RH, Kapur NK.. Left ventricular unloading before reperfusion promotes functional recovery after acute myocardial infarction. J Am Coll Cardiol 2018;72:501–514. PubMed PMC

Kapur NK, Alkhouli MA, DeMartini TJ, Faraz H, George ZH, Goodwin MJ, Hernandez-Montfort JA, Iyer VS, Josephy N, Kalra S, Kaki A, Karas RH, Kimmelstiel CD, Koenig GC, Lau E, Lotun K, Madder RD, Mannino SF, Meraj PM, Moreland JA, Moses JW, Kim RL, Schreiber TL, Udelson JE, Witzke C, Wohns DHW, O'Neill WW.. Unloading the left ventricle before reperfusion in patients with anterior ST-segment-elevation myocardial infarction. Circulation 2019;139:337–346. PubMed

Alqarqaz M, Basir M, Alaswad K, O’Neill W.. Effects of Impella on coronary perfusion in patients with critical coronary artery stenosis. Circ Cardiovasc Interv 2018;11:e005870. PubMed

Neumann F-J, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, Byrne RA, Collet J-P, Falk V, Head SJ, Jüni P, Kastrati A, Koller A, Kristensen SD, Niebauer J, Richter DJ, Seferovic PM, Sibbing D, Stefanini GG, Windecker S, Yadav R, Zembala MO; ESC Scientific Document Group. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J 2019;40:87–165. PubMed

Unverzagt S, Buerke M, de Waha A, Haerting J, Pietzner D, Seyfarth M, Thiele H, Werdan K, Zeymer U, Prondzinsky R.. Intra-aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shock. Cochrane Database Syst Rev 2015;3:CD007398. PubMed PMC

Thiele H, Zeymer U, Neumann F-J, Ferenc M, Olbrich H-G, Hausleiter J, Richardt G, Hennersdorf M, Empen K, Fuernau G, Desch S, Eitel I, Hambrecht R, Fuhrmann J, Böhm M, Ebelt H, Schneider S, Schuler G, Werdan K; IABP-SHOCK II Trial Investigators. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med 2012;367:1287–1296. PubMed

Thiele H, Zeymer U, Thelemann N, Neumann FJ, Hausleiter J, Abdel-Wahab M, Meyer-Saraei R, Fuernau G, Eitel I, Hambrecht R, Böhm M, Werdan K, Felix SB, Hennersdorf M, Schneider S, Ouarrak T, Desch S, de Waha-Thiele S; IABPSHOCK II Trial (Intraaortic Balloon Pump in Cardiogenic Shock II) Investigators. Intraaortic Balloon Pump in Cardiogenic Shock Complicating Acute Myocardial Infarction: Long-Term 6-Year Outcome of the Randomized IABP-SHOCK II Trial. Circulation 2018. PubMed

O'Neill WW, Grines C, Schreiber T, Moses J, Maini B, Dixon SR, Ohman EM.. Analysis of outcomes for 15,259 US patients with acute myocardial infarction cardiogenic shock (AMICS) supported with the Impella device. Am Heart J 2018;202:33–38. PubMed

Schrage B, Ibrahim K, Loehn T, Werner N, Sinning J-M, Pappalardo F, Pieri M, Skurk C, Lauten A, Landmesser U, Westenfeld R, Horn P, Pauschinger M, Eckner D, Twerenbold R, Nordbeck P, Salinger T, Abel P, Empen K, Busch MC, Felix SB, Sieweke J-T, Møller JE, Pareek N, Hill J, MacCarthy P, Bergmann MW, Henriques JPS, Möbius-Winkler S, Schulze PC, Ouarrak T, Zeymer U, Schneider S, Blankenberg S, Thiele H, Schäfer A, Westermann D.. Impella support for acute myocardial infarction complicated by cardiogenic shock. Circulation 2019;139:1249–1258. PubMed

Ouweneel DM, Eriksen E, Seyfarth M, Henriques JPS.. Percutaneous mechanical circulatory support versus intra-aortic balloon pump for treating cardiogenic shock: meta-analysis. J Am Coll Cardiol 2017;69:358–360. PubMed

Ouweneel DM, Schotborgh JV, Limpens J, Sjauw KD, Engström AE, Lagrand WK, Cherpanath TGV, Driessen AHG, de Mol BAJM, Henriques JPS.. Extracorporeal life support during cardiac arrest and cardiogenic shock: a systematic review and meta-analysis. Intensive Care Med 2016;42:1922–1934. PubMed PMC

Stub D, Bernard S, Pellegrino V, Smith K, Walker T, Sheldrake J, Hockings L, Shaw J, Duffy SJ, Burrell A, Cameron P, Smit DV, Kaye DM.. Refractory cardiac arrest treated with mechanical CPR, hypothermia, ECMO and early reperfusion (the CHEER trial). Resuscitation 2015;86:88–94. PubMed

Soar J, Donnino MW, Maconochie I, Aickin R, Atkins DL, Andersen LW, Berg KM, Bingham R, Böttiger BW, Callaway CW, Couper K, Couto TB, de Caen AR, Deakin CD, Drennan IR, Guerguerian A-M, Lavonas EJ, Meaney PA, Nadkarni VM, Neumar RW, Ng K-C, Nicholson TC, Nuthall GA, Ohshimo S, O'Neil BJ, Ong GY-K, Paiva EF, Parr MJ, Reis AG, Reynolds JC, Ristagno G, Sandroni C, Schexnayder SM, Scholefield BR, Shimizu N, Tijssen JA, Van de Voorde P, Wang T-L, Welsford M, Hazinski MF, Nolan JP, Morley PT; ILCOR Collaborators. 2018 international consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment recommendations summary. Circulation 2018;138:e714–e730. PubMed

Baran DA, Grines CL, Bailey S, Burkhoff D, Hall SA, Henry TD, Hollenberg SM, Kapur NK, O'Neill W, Ornato JP, Stelling K, Thiele H, van Diepen S, Naidu SS.. SCAI clinical expert consensus statement on the classification of cardiogenic shock: this document was endorsed by the American College of Cardiology (ACC), the American Heart Association (AHA), the Society of Critical Care Medicine (SCCM), and the Society of Thoracic Surgeons (STS) in April 2019. Catheter Cardiovasc Interv 2019;94:29–37. PubMed

Dhruva SS, Mortazavi BJ, Desai NR.. Association of use of an intravascular microaxial left ventricular assist device vs intra-aortic balloon pump with in-hospital mortality and major bleeding among patients with acute myocardial infarction complicated by cardiogenic shock. JAMA 2020;324:303. PubMed PMC

Gramegna M, Beneduce A, Bertoldi LF, Pagnesi M, Marini C, Pazzanese V, Camici PG, Chieffo A, Pappalardo F.. Impella RP support in refractory right ventricular failure complicating acute myocardial infarction with unsuccessful right coronary artery revascularization. Int J Cardiol 2020;302:135–137. PubMed

Anderson MB, Goldstein J, Milano C, Morris LD, Kormos RL, Bhama J, Kapur NK, Bansal A, Garcia J, Baker JN, Silvestry S, Holman WL, Douglas PS, O’Neill W.. Benefits of a novel percutaneous ventricular assist device for right heart failure: the prospective RECOVER RIGHT study of the Impella RP device. J Heart Lung Transplant 2015;34:1549–1560. PubMed

Ravichandran AK, Baran DA, Stelling K, Cowger JA, Salerno CT.. Outcomes with the tandem protek duo dual-lumen percutaneous right ventricular assist device. ASAIO J 2018;64:570–572. PubMed

Aggarwal V, Einhorn BN, Cohen HA.. Current status of percutaneous right ventricular assist devices: First-in-man use of a novel dual lumen cannula. Catheter Cardiovasc Interv 2016;88:390–396. PubMed

Suguta M, Hoshizaki H, Anno M, Naito S, Tada H, Nogami A, Oshima S, Taniguchi K.. Right ventricular infarction with cardiogenic shock treated with percutaneous cardiopulmonary support: a case report. Jpn Circ J 1999;63:813–815. PubMed

De Silva RJ, Soto C, Spratt P.. Extra corporeal membrane oxygenation as right heart support following left ventricular assist device placement: a new cannulation technique. Heart Lung Circ 2012;21:218–220. PubMed

Scherer M, Sirat AS, Moritz A, Martens S.. Extracorporeal membrane oxygenation as perioperative right ventricular support in patients with biventricular failure undergoing left ventricular assist device implantation. Eur J Cardiothorac Surg 2011;39:939–944; discussion 944. PubMed

Rao P, Mosier J, Malo J, Dotson V, Mogan C, Smith R, Keller R, Slepian M, Khalpey Z.. Peripheral VA-ECMO with direct biventricular decompression for refractory cardiogenic shock. Perfusion 2018;33:493–495. PubMed

Aubin H, Petrov G, Dalyanoglu H, Richter M, Saeed D, Akhyari P, Kindgen-Milles D, Albert A, Lichtenberg A.. Four-year experience of providing mobile extracorporeal life support to out-of-center patients within a suprainstitutional network-outcome of 160 consecutively treated patients. Resuscitation 2017;121:151–157. PubMed

Sakamoto T, Morimura N, Nagao K, Asai Y, Yokota H, Nara S, Hase M, Tahara Y, Atsumi T.. Extracorporeal cardiopulmonary resuscitation versus conventional cardiopulmonary resuscitation in adults with out-of-hospital cardiac arrest: a prospective observational study. Resuscitation 2014;85:762–768. PubMed

Russo JJ, Aleksova N, Pitcher I, Couture E, Parlow S, Faraz M, Visintini S, Simard T, Di Santo P, Mathew R, So DY, Takeda K, Garan AR, Karmpaliotis D, Takayama H, Kirtane AJ, Hibbert B.. Left ventricular unloading during extracorporeal membrane oxygenation in patients with cardiogenic shock. J Am Coll Cardiol 2019;73:654–662. PubMed

Mehta SR, Eikelboom JW, Natarajan MK, Diaz R, Yi C, Gibbons RJ, Yusuf S.. Impact of right ventricular involvement on mortality and morbidity in patients with inferior myocardial infarction. J Am Coll Cardiol 2001;37:37–43. PubMed

Patel SM, Lipinski J, Al-Kindi SG, Patel T, Saric P, Li J, Nadeem F, Ladas T, Alaiti A, Phillips A, Medalion B, Deo S, Elgudin Y, Costa MA, Osman MN, Attizzani GF, Oliveira GH, Sareyyupoglu B, Bezerra HG.. Simultaneous venoarterial extracorporeal membrane oxygenation and percutaneous left ventricular decompression therapy with Impella is associated with improved outcomes in refractory cardiogenic shock. ASAIO J 2019;65:21–28. PubMed

Pappalardo F, Scandroglio AM, Latib A.. Full percutaneous biventricular support with two Impella pumps: the Bi-Pella approach. ESC Heart Fail 2018;5:368–371. PubMed PMC

Kuchibhotla S, Esposito ML, Breton C, Pedicini R, Mullin A, O'Kelly R, Anderson M, Morris DL, Batsides G, Ramzy D, Grise M, Pham DT, Kapur NK.. Acute biventricular mechanical circulatory support for cardiogenic shock. J Am Heart Assoc 2017;6:e006670. PubMed PMC

Repessé X, Au SM, Bréchot N, Trouillet J-L, Leprince P, Chastre J, Combes A, Luyt C-E.. Recombinant factor VIIa for uncontrollable bleeding in patients with extracorporeal membrane oxygenation: report on 15 cases and literature review. Crit Care 2013;17:R55. PubMed PMC

Cheng R, Hachamovitch R, Kittleson M, Patel J, Arabia F, Moriguchi J, Esmailian F, Azarbal B.. Complications of extracorporeal membrane oxygenation for treatment of cardiogenic shock and cardiac arrest: a meta-analysis of 1,866 adult patients. Ann Thorac Surg 2014;97:610–616. PubMed

Tanaka D, Hirose H, Cavarocchi N, Entwistle JWC.. The impact of vascular complications on survival of patients on venoarterial extracorporeal membrane oxygenation. Ann Thorac Surg 2016;101:1729–1734. PubMed

Heilmann C, Geisen U, Beyersdorf F, Nakamura L, Benk C, Trummer G, Berchtold-Herz M, Schlensak C, Zieger B.. Acquired von Willebrand syndrome in patients with extracorporeal life support (ECLS). Intensive Care Med 2012;38:62–68. PubMed

Redfors B, Watson BM, McAndrew T, Palisaitis E, Francese DP, Razavi M, Safirstein J, Mehran R, Kirtane AJ, Généreux P.. Mortality, length of stay, and cost implications of procedural bleeding after percutaneous interventions using large-bore catheters. JAMA Cardiol 2017;2:798–802. PubMed PMC

Schmidt M, Bréchot N, Hariri S, Guiguet M, Luyt CE, Makri R, Leprince P, Trouillet J-L, Pavie A, Chastre J, Combes A.. Nosocomial infections in adult cardiogenic shock patients supported by venoarterial extracorporeal membrane oxygenation. Clin Infect Dis 2012;55:1633–1641. PubMed PMC

Muller G, Flecher E, Lebreton G, Luyt C-E, Trouillet J-L, Bréchot N, Schmidt M, Mastroianni C, Chastre J, Leprince P, Anselmi A, Combes A.. The ENCOURAGE mortality risk score and analysis of long-term outcomes after VA-ECMO for acute myocardial infarction with cardiogenic shock. Intensive Care Med 2016;42:370–378. PubMed

O'Neill WW, Schreiber T, Wohns DHW, Rihal C, Naidu SS, Civitello AB, Dixon SR, Massaro JM, Maini B, Ohman EM.. The current use of Impella 2.5 in acute myocardial infarction complicated by cardiogenic shock: results from the USpella Registry. J Interv Cardiol 2014;27:1–11. PubMed PMC

Burzotta F, Trani C, Doshi SN, Townend J, van Geuns RJ, Hunziker P, Schieffer B, Karatolios K, Møller JE, Ribichini FL, Schäfer A, Henriques JPS.. Impella ventricular support in clinical practice: Collaborative viewpoint from a European expert user group. Int J Cardiol 2015;201:684–691. PubMed

Combes A, Leprince P, Luyt CE, Bonnet N, Trouillet JL, Léger P, Pavie A, Chastre J.. Outcomes and long-term quality-of-life of patients supported by extracorporeal membrane oxygenation for refractory cardiogenic shock. Crit Care Med 2008;36:1404–1411. PubMed

Le Guennec L, Cholet C, Huang F, Schmidt M, Bréchot N, Hékimian G, Besset S, Lebreton G, Nieszkowska A, Leprince P, Combes A, Luyt CE.. Ischemic and hemorrhagic brain injury during venoarterial-extracorporeal membrane oxygenation. Ann Intensive Care 2018;8:129. PubMed PMC

Lorusso R, Barili F, Mauro MD, Gelsomino S, Parise O, Rycus PT, Maessen J, Mueller T, Muellenbach R, Belohlavek J, Peek G, Combes A, Frenckner B, Pesenti A, Thiagarajan RR.. In-hospital neurologic complications in adult patients undergoing venoarterial extracorporeal membrane oxygenation: results from the Extracorporeal Life Support Organization Registry. Crit Care Med 2016;44:e964–e972. PubMed

Kimmoun A, Oulehri W, Sonneville R, Grisot P-H, Zogheib E, Amour J, Aissaoui N, Megarbane B, Mongardon N, Renou A, Schmidt M, Besnier E, Delmas C, Dessertaine G, Guidon C, Nesseler N, Labro G, Rozec B, Pierrot M, Helms J, Bougon D, Chardonnal L, Medard A, Ouattara A, Girerd N, Lamiral Z, Borie M, Ajzenberg N, Levy B.. Prevalence and outcome of heparin-induced thrombocytopenia diagnosed under veno-arterial extracorporeal membrane oxygenation: a retrospective nationwide study. Intensive Care Med 2018;44:1460–1469. PubMed

Amin AP, Spertus JA, Curtis JP, Desai N, Masoudi FA, Bach RG, McNeely C, Al-Badarin F, House JA, Kulkarni V, Rao SV.. The Evolving Landscape of Impella® Use in the United States among patients undergoing percutaneous coronary intervention with mechanical circulatory support. Circulation 2020;141:273–284. PubMed

Smith L, Peters A, Mazimba S, Ragosta M, Taylor AM.. Outcomes of patients with cardiogenic shock treated with TandemHeart® percutaneous ventricular assist device: importance of support indication and definitive therapies as determinants of prognosis. Catheter Cardiovasc Interv 2018;92:1173–1181. PubMed

Pineton de Chambrun M, Bréchot N, Combes A.. Venoarterial extracorporeal membrane oxygenation in cardiogenic shock: indications, mode of operation, and current evidence. Curr Opin Crit Care 2019;25:397–402. PubMed

Petroni T, Harrois A, Amour J, Lebreton G, Brechot N, Tanaka S, Luyt C-E, Trouillet J-L, Chastre J, Leprince P, Duranteau J, Combes A.. Intra-aortic balloon pump effects on macrocirculation and microcirculation in cardiogenic shock patients supported by venoarterial extracorporeal membrane oxygenation. Crit Care Med 2014;42:2075–2082. PubMed

Schrage B, Burkhoff D, Rübsamen N, Becher PM, Schwarzl M, Bernhardt A, Grahn H, Lubos E, Söffker G, Clemmensen P, Reichenspurner H, Blankenberg S, Westermann D.. Unloading of the left ventricle during venoarterial extracorporeal membrane oxygenation therapy in cardiogenic shock. JACC Heart Fail 2018;6:1035–1043. PubMed

Pappalardo F, Schulte C, Pieri M, Schrage B, Contri R, Soeffker G, Greco T, Lembo R, Müllerleile K, Colombo A, Sydow K, De Bonis M, Wagner F, Reichenspurner H, Blankenberg S, Zangrillo A, Westermann D.. Concomitant implantation of Impella(R) on top of veno-arterial extracorporeal membrane oxygenation may improve survival of patients with cardiogenic shock. Eur J Heart Fail 2017;19:404–412. PubMed

Bréchot N, Demondion P, Santi F, Lebreton G, Pham T, Dalakidis A, Gambotti L, Luyt C-E, Schmidt M, Hekimian G, Cluzel P, Chastre J, Leprince P, Combes A.. Intra-aortic balloon pump protects against hydrostatic pulmonary oedema during peripheral venoarterial-extracorporeal membrane oxygenation. Eur Heart J Acute Cardiovasc Care 2018;7:62–69. PubMed

Abrams D, Combes A, Brodie D.. Extracorporeal membrane oxygenation in cardiopulmonary disease in adults. J Am Coll Cardiol 2014;63:2769–2778. PubMed

Brodie D, Slutsky AS, Combes A.. Extracorporeal life support for adults with respiratory failure and related indications: a review. JAMA 2019;322:557–568. PubMed

MacLaren G, Combes A, Bartlett RH.. Contemporary extracorporeal membrane oxygenation for adult respiratory failure: life support in the new era. Intensive Care Med 2012;38:210–220. PubMed

Yang F, Hou D, Wang J.. Vascular complications in adult postcardiotomy cardiogenic shock patients receiving venoarterial extracorporeal membrane oxygenation. Ann Intensive Care 2018;8:72. PubMed PMC

Pineton de Chambrun M, Combes A, Hekimian G.. Contrast-enhanced Doppler echography to assess position of the distal leg perfusion line in patients on venoarterial extracorporeal membrane oxygenation: a preliminary study. Artif Organs 2019;43:605–606. PubMed

Danial P, Hajage D, Nguyen LS, Mastroianni C, Demondion P, Schmidt M, Bouglé A, Amour J, Leprince P, Combes A, Lebreton G.. Percutaneous versus surgical femoro-femoral veno-arterial ECMO: a propensity score matched study. Intensive Care Med 2018;44:2153–2161. PubMed

Lockie CJA, Gillon SA, Barrett NA, Taylor D, Mazumder A, Paramesh K, Rowland K, Daly K, Camporota L, Meadows CIS, Glover GW, Ioannou N, Langrish CJ, Tricklebank S, Retter A, Wyncoll DLA.. Severe respiratory failure, extracorporeal membrane oxygenation, and intracranial hemorrhage. Crit Care Med 2017;45:1642–1649. PubMed

Jia D, Neo R, Lim E, Seng TC, MacLaren G, Ramanathan K.. Autopsy and clinical discrepancies in patients undergoing extracorporeal membrane oxygenation: a case series. Cardiovasc Pathol 2019;41:24–28. PubMed

Fletcher-Sandersjöö A, Thelin EP, Bartek J, Broman M, Sallisalmi M, Elmi-Terander A, Bellander B-M Jr. Incidence, outcome, and predictors of intracranial hemorrhage in adult patients on extracorporeal membrane oxygenation: a systematic and narrative review. Front Neurol 2018;9:548. PubMed PMC

Sniecinski RM, Bennett-Guerrero E, Shore-Lesserson L.. Anticoagulation management and heparin resistance during cardiopulmonary bypass: a survey of Society of Cardiovascular Anesthesiologists Members. Anesth Analg 2019;129:e41–e44. PubMed PMC

Rougé A, Pelen F, Durand M, Schwebel C.. Argatroban for an alternative anticoagulant in HIT during ECMO. J Intensive Care 2017;5:39. PubMed PMC

Selleng S, Selleng K.. Heparin-induced thrombocytopenia in cardiac surgery and critically ill patients. Thromb Haemost 2016;116:843–851. PubMed

Eikelboom JW, Connolly SJ, Brueckmann M, Granger CB, Kappetein AP, Mack MJ, Blatchford J, Devenny K, Friedman J, Guiver K, Harper R, Khder Y, Lobmeyer MT, Maas H, Voigt J-U, Simoons ML, Van de Werf F; RE-ALIGN Investigators. Dabigatran versus warfarin in patients with mechanical heart valves. N Engl J Med 2013;369:1206–1214. PubMed

Reed BN, DiDomenico RJ, Allender JE, Coons JC, Cox JF, Johnson D, Oliphant CS, Jennings DL.. Survey of anticoagulation practices with the Impella percutaneous ventricular assist device at high-volume centers. J Interv Cardiol 2019;2019:3791307. PubMed PMC

Arachchillage DRJ, Kamani F, Deplano S, Banya W, Laffan M.. Should we abandon the APTT for monitoring unfractionated heparin? Thromb Res 2017;157:157–161. PubMed

Panigada M, Ei G, Brioni M, Panarello G, Protti A, Grasselli G, Occhipinti G, Novembrino C, Consonni D, Arcadipane A, Gattinoni L, Pesenti A.. Thromboelastography-based anticoagulation management during extracorporeal membrane oxygenation: a safety and feasibility pilot study. Ann Intensive Care 2018;8:7. PubMed PMC

Raiten JM, Wong ZZ, Spelde A, Littlejohn JE, Augoustides JGT, Gutsche JT.. Anticoagulation and transfusion therapy in patients requiring extracorporeal membrane oxygenation. J Cardiothorac Vasc Anesth 2017;31:1051–1059. PubMed

Abiomed®. Impella Program Protocols & Tools. Protected PCI Community. https://www.protectedpci.com/wp-content/uploads/2019/09/Impella-Program-Protocols-and-Tools.pdf (10 March 2020).

Vandenbriele C, Vanassche T, Price S.. Why we need safer anticoagulant strategies for patients on short-term percutaneous mechanical circulatory support. Intensive Care Med 2020;46:771–774. PubMed

Valgimigli M, Bueno H, Byrne RA, Collet J-P, Costa F, Jeppsson A, Jüni P, Kastrati A, Kolh P, Mauri L, Montalescot G, Neumann F-J, Petricevic M, Roffi M, Steg PG, Windecker S, Zamorano JL, Levine GN; ESC National Cardiac Societies. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2018;39:213–260. PubMed

Schumann J, Henrich EC, Strobl H, Prondzinsky R, Weiche S, Thiele H, Werdan K, Frantz S, Unverzagt S.. Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome. Cochrane Database Syst Rev 2018;1:CD009669. PubMed PMC

Jolly S, Newton G, Horlick E, Seidelin PH, Ross HJ, Husain M, Dzavik V.. Effect of vasopressin on hemodynamics in patients with refractory cardiogenic shock complicating acute myocardial infarction. Am J Cardiol 2005;96:1617–1620. PubMed

De Backer D, Biston P, Devriendt J, Madl C, Chochrad D, Aldecoa C, Brasseur A, Defrance P, Gottignies P, Vincent J-L.. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med 2010;362:779–789. PubMed

Mebazaa A, Combes A, van Diepen S, Hollinger A, Katz JN, Landoni G, Hajjar LA, Lassus J, Lebreton G, Montalescot G, Park JJ, Price S, Sionis A, Yannopolos D, Harjola V-P, Levy B, Thiele H.. Management of cardiogenic shock complicating myocardial infarction. Intensive Care Med 2018;44:760–773. PubMed

Levy B, Perez P, Perny J, Thivilier C, Gerard A.. Comparison of norepinephrine-dobutamine to epinephrine for hemodynamics, lactate metabolism, and organ function variables in cardiogenic shock. A prospective, randomized pilot study. Critical Care Medicine 2011;39:450–455. PubMed

Léopold V, Gayat E, Pirracchio R, Spinar J, Parenica J, Tarvasmäki T, Lassus J, Harjola V-P, Champion S, Zannad F, Valente S, Urban P, Chua H-R, Bellomo R, Popovic B, Ouweneel DM, Henriques JPS, Simonis G, Lévy B, Kimmoun A, Gaudard P, Basir MB, Markota A, Adler C, Reuter H, Mebazaa A, Chouihed T.. Epinephrine and short-term survival in cardiogenic shock: an individual data meta-analysis of 2583 patients. Intensive Care Med 2018;44:847–856. PubMed

Levy B, Clere-Jehl R, Legras A, Morichau-Beauchant T, Leone M, Frederique G, Quenot J-P, Kimmoun A, Cariou A, Lassus J, Harjola V-P, Meziani F, Louis G, Rossignol P, Duarte K, Girerd N, Mebazaa A, Vignon P, Mattei M, Thivilier C, Perez P, Auchet T, Fritz C, Boisrame-Helme J, Mercier E, Garot D, Perny J, Gette S, Hammad E, Vigne C, Dargent A, Andreu P, Guiot P.. Epinephrine versus norepinephrine for cardiogenic shock after acute myocardial infarction. J Am Coll Cardiol 2018;72:173–182. PubMed

Takeda K, Takayama H, Colombo PC, Yuzefpolskaya M, Fukuhara S, Han J, Kurlansky P, Mancini DM, Naka Y.. Incidence and clinical significance of late right heart failure during continuous-flow left ventricular assist device support. J Heart Lung Transplant 2015;34:1024–1032. PubMed

Bouchez S, Fedele F, Giannakoulas G, Gustafsson F, Harjola V-P, Karason K, Kivikko M, von Lewinski D, Oliva F, Papp Z, Parissis J, Pollesello P, Pölzl G, Tschöpe C.. Levosimendan in acute and advanced heart failure: an expert perspective on posology and therapeutic application. Cardiovasc Drugs Ther 2018;32:617–624. PubMed PMC

Hetzer DM. Myocardial recovery during mechanical circulatory support: weaning and explantation criteria. Heart Lung Vessel 2015;7:280–288. PubMed PMC

Aissaoui N, Luyt C-E, Leprince P, Trouillet J-L, Léger P, Pavie A, Diebold B, Chastre J, Combes A.. Predictors of successful extracorporeal membrane oxygenation (ECMO) weaning after assistance for refractory cardiogenic shock. Intensive Care Med 2011;37:1738–1745. j PubMed

Aissaoui N, Guerot E, Combes A, Delouche A, Chastre J, Leprince P, Leger P, Diehl JL, Fagon JY, Diebold B.. Two-dimensional strain rate and Doppler tissue myocardial velocities: analysis by echocardiography of hemodynamic and functional changes of the failed left ventricle during different degrees of extracorporeal life support. J Am Soc Echocardiogr 2012;25:632–640. PubMed

Chen Y-S, Chao A, Yu H-Y, Ko W-J, Wu I-H, Chen RJ-C, Huang S-C, Lin F-Y, Wang S-S.. Analysis and results of prolonged resuscitation in cardiac arrest patients rescued by extracorporeal membrane oxygenation. J Am Coll Cardiol 2003;41:197–203. PubMed

Chen Y-S, Lin J-W, Yu H-Y, Ko W-J, Jerng J-S, Chang W-T, Chen W-J, Huang S-C, Chi N-H, Wang C-H, Chen L-C, Tsai P-R, Wang S-S, Hwang J-J, Lin F-Y.. Cardiopulmonary resuscitation with assisted extracorporeal life-support versus conventional cardiopulmonary resuscitation in adults with in-hospital cardiac arrest: an observational study and propensity analysis. Lancet 2008;372:554–561. PubMed

Bakhtiary F, Keller H, Dogan S, Dzemali O, Oezaslan F, Meininger D, Ackermann H, Zwissler B, Kleine P, Moritz A.. Venoarterial extracorporeal membrane oxygenation for treatment of cardiogenic shock: clinical experiences in 45 adult patients. J Thorac Cardiovasc Surg 2008;135:382–388. PubMed

Smedira NG, Moazami N, Golding CM, McCarthy PM, Apperson-Hansen C, Blackstone EH, Cosgrove DM.. Clinical experience with 202 adults receiving extracorporeal membrane oxygenation for cardiac failure: survival at five years. J Thorac Cardiovasc Surg 2001;122:92–102. PubMed

Pagani FD, Lynch W, Swaniker F, Dyke DB, Bartlett R, Koelling T, Moscucci M, Deeb GM, Bolling S, Monaghan H, Aaronson KD.. Extracorporeal life support to left ventricular assist device bridge to heart transplant: a strategy to optimize survival and resource utilization. Circulation 1999;100:II206–II210. PubMed

Doll N, Kiaii B, Borger M, Bucerius J, Krämer K, Schmitt DV, Walther T, Mohr FW.. Five-year results of 219 consecutive patients treated with extracorporeal membrane oxygenation for refractory postoperative cardiogenic shock. Ann Thorac Surg 2004;77:151–157; discussion 157. PubMed

Mégarbane B, Leprince P, Deye N, Résière D, Guerrier G, Rettab S, Théodore J, Karyo S, Gandjbakhch I, Baud FJ.. Emergency feasibility in medical intensive care unit of extracorporeal life support for refractory cardiac arrest. Intensive Care Med 2007;33:758–764. PubMed

Chen J-S, Ko W-J, Yu H-Y, Lai L-P, Huang S-C, Chi N-H, Tsai C-H, Wang S-S, Lin F-Y, Chen Y-S.. Analysis of the outcome for patients experiencing myocardial infarction and cardiopulmonary resuscitation refractory to conventional therapies necessitating extracorporeal life support rescue. Crit Care Med 2006;34:950–957. PubMed

Pages ON, Aubert S, Combes A, Luyt CE, Pavie A, Léger P, Gandjbakhch I, Leprince P.. Paracorporeal pulsatile biventricular assist device versus extracorporal membrane oxygenation-extracorporal life support in adult fulminant myocarditis. J Thorac Cardiovasc Surg 2009;137:194–197. PubMed

Asaumi Y, Yasuda S, Morii I, Kakuchi H, Otsuka Y, Kawamura A, Sasako Y, Nakatani T, Nonogi H, Miyazaki S.. Favourable clinical outcome in patients with cardiogenic shock due to fulminant myocarditis supported by percutaneous extracorporeal membrane oxygenation. Eur Heart J 2005;26:2185–2192. PubMed

Jan S-L, Lin S-J, Fu Y-C, Chi C-S, Wang C-C, Wei H-J, Chang Y, Hwang B, Chen P-Y, Huang F-L, Lin M-C.. Extracorporeal life support for treatment of children with enterovirus 71 infection-related cardiopulmonary failure. Intensive Care Med 2010;36:520–527. PubMed

Fiser SM, Tribble CG, Kaza AK, Long SM, Zacour RK, Kern JA, Kron IL.. When to discontinue extracorporeal membrane oxygenation for postcardiotomy support. Ann Thorac Surg 2001;71:210–214. PubMed

Chen Y-S, Ko W-J, Chi N-H, Wu I-H, Huang S-C, Chen RJ-C, Chou N-K, Hsu R-B, Lin F-Y, Wang S-S, Chu S-H, Yu H-Y.. Risk factor screening scale to optimize treatment for potential heart transplant candidates under extracorporeal membrane oxygenation. Am J Transplant 2004;4:1818–1825. PubMed

Vieillard-Baron A, Slama M, Cholley B, Janvier G, Vignon P.. Echocardiography in the intensive care unit: from evolution to revolution? Intensive Care Med 2008;34:243–249. PubMed

Combes A, Arnoult F, Trouillet JL.. Tissue Doppler imaging estimation of pulmonary artery occlusion pressure in ICU patients. Intensive Care Med 2004;30:75–81. PubMed

Park YS, Park J-H, Ahn KT, Jang WI, Park HS, Kim JH, Lee J-H, Choi SW, Jeong J-O, Seong I-W.. Usefulness of mitral annular systolic velocity in the detection of left ventricular systolic dysfunction: comparison with three dimensional echocardiographic data. J Cardiovasc Ultrasound 2010;18:1–5. PubMed PMC

Pulsatile Left Ventricular Assistance in High-Risk Percutaneous Coronary Interventions: Short-Term Outcomes